March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the company.

In this role, Dr. Yamashita will provide strategic advisory and development support across several key areas, including:

March 5, 2026 — Cassling is now accepting applications for the 2026 Imaging for Impact Award, a national recognition program celebrating imaging professionals and healthcare teams who are improving patient outcomes and strengthening access to care in their communities. Applications are being accepted until April 1, 2026.

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European Congress of Radiology 2026 (ECR 2026), in Vienna, Austria.

At this year's congress, independent studies evaluating the clinical value of Lunit INSIGHT MMG, Scorecard, and Lunit INSIGHT CXR will be presented. Thirteen abstracts have been selected for oral presentations, while eight will be presented as posters.

Feb. 27, 2026 — NYC Health + Hospitals/Jacobi | North Central Bronx recently unveiled a new $2 million MRI suite at the North Central Bronx campus with renovated rooms and upgraded MRI machines.

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded capabilities of its MEDRAD MRXperion magnetic resonance (MR) injection system, a power injector designed to support efficient workflow and consistent contrast delivery across a broad range of MR environments.

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be integrated into DeepHealth, RadNet’s wholly owned subsidiary. The acquisition further expands DeepHealth’s AI-powered health informatics solutions and services, making it the largest provider of radiology clinical AI solutions worldwide.1

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA De Novo clearance for its flagship Delivery Date AI technology, a cloud-based Software as a Medical Device (SaMD) that determines a Predicted Delivery Date (PDD) solely from standard ultrasound images and seamless integration into current OB/MFM prenatal visit workflows; PDD is provided in real-time for actionable decision-making by the clinical team.

March 3, 2026 — MedDream will present its cloud-native, AI-ready universal DICOM viewer in the Amazon Web Services (AWS) in-booth theater at HIMSS 2026 in Las Vegas.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now